Loading
Hematological Disorders and Diagnostics / Streptococcal Infections and Treatments · Journal article
The Lancet Regional Health - Americas · September 1, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a narrative review of epidemiologic literature on rheumatic heart disease (RHD) in Latin America that emphasizes the persistence of RHD as a public health burden in the region despite global declines, and notes that recent echocardiographic screening has uncovered higher rates of subclinical disease than previously appreciated. The work does not present systematic evidence synthesis or new quantitative findings; it is a qualitative overview intended to highlight gaps and vulnerable populations.
Narrative review. Literature on RHD epidemiology in Latin America; specific inclusion and exclusion criteria not stated.. Latin America.
RHD affects over 55 million individuals worldwide, accounting for more than 390,000 deaths annually Recent echocardiographic screening initiatives revealed alarming rates of subclinical RHD in Latin American schoolchildren and young adults Region-specific RHD epidemiologic data are scarce; most clinical studies date to the 1990s
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
Clinicians and public health professionals should recognize that RHD remains a significant burden in Latin America despite global declines, and that subclinical disease prevalence in youth may be higher than older epidemiologic literature suggests. However, this review does not provide quantitative data on regional incidence, prevalence, or outcomes to guide specific practice changes.
A narrative review synthesizing scattered epidemiologic data on RHD in Latin America, lacking a systematic methodology, meta-analysis, or new primary data to support quantitative claims beyond citation of existing estimates.
As stated by the source record.
Quoted from the source exactly as published.
Clinicians and public health professionals should recognize that RHD remains a significant burden in Latin America despite global declines, and that subclinical disease prevalence in youth may be higher than older epidemiologic literature suggests. However, this review does not provide quantitative data on regional incidence, prevalence, or outcomes to guide specific practice changes.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
Rheumatic heart disease (RHD) remains a significant public health challenge in Latin America, disproportionately affecting vulnerable populations despite global declines in disease prevalence and mortality. It is known that RHD affects over 55 million individuals worldwide, accounting for more than 390,000 deaths annually. However, region-specific RHD epidemiologic data are scarce, and most clinical studies on RHD epidemiology date back to the 1990s. On the other hand, the emergence of echocardiographic screening initiatives in the last decade reinforced the burden of the disease, revealing alarming rates of subclinical RHD in Latin American schoolchildren and young adults. This comprehensive review focused on epidemiologic data on RHD from Latin America and highlighted subgroups at highest risk for the disease.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.